TTRX · Turn Therapeutics Inc.

Substantial doubt about the company's ability to continue as a going concern.

“Our capital resources may not be sufficient to fund operations through at least the next 12 months from the date that these unaudited condensed consolidated financial statements as of March 31, 2026 are issued based on our expected cash needs, which raises substantial doubt about our ability to continue as a going concern.”